425 related articles for article (PubMed ID: 28697992)
1. PDE3 inhibition by C-type natriuretic peptide-induced cGMP enhances cAMP-mediated signaling in both non-failing and failing hearts.
Meier S; Andressen KW; Aronsen JM; Sjaastad I; Hougen K; Skomedal T; Osnes JB; Qvigstad E; Levy FO; Moltzau LR
Eur J Pharmacol; 2017 Oct; 812():174-183. PubMed ID: 28697992
[TBL] [Abstract][Full Text] [Related]
2. Natriuretic peptides increase beta1-adrenoceptor signalling in failing hearts through phosphodiesterase 3 inhibition.
Qvigstad E; Moltzau LR; Aronsen JM; Nguyen CH; Hougen K; Sjaastad I; Levy FO; Skomedal T; Osnes JB
Cardiovasc Res; 2010 Mar; 85(4):763-72. PubMed ID: 19900965
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation of C-type natriuretic peptide-induced cGMP and functional responses by PDE2 and PDE3 in failing myocardium.
Moltzau LR; Meier S; Aronsen JM; Afzal F; Sjaastad I; Skomedal T; Osnes JB; Levy FO; Qvigstad E
Naunyn Schmiedebergs Arch Pharmacol; 2014 May; 387(5):407-17. PubMed ID: 24424715
[TBL] [Abstract][Full Text] [Related]
4. Agents increasing cyclic GMP amplify 5-HT4-elicited positive inotropic response in failing rat cardiac ventricle.
Afzal F; Qvigstad E; Aronsen JM; Moltzau LR; Sjaastad I; Skomedal T; Osnes JB; Levy FO
Naunyn Schmiedebergs Arch Pharmacol; 2011 Dec; 384(6):543-53. PubMed ID: 21901315
[TBL] [Abstract][Full Text] [Related]
5. Different compartmentation of responses to brain natriuretic peptide and C-type natriuretic peptide in failing rat ventricle.
Moltzau LR; Aronsen JM; Meier S; Skogestad J; Ørstavik Ø; Lothe GB; Sjaastad I; Skomedal T; Osnes JB; Levy FO; Qvigstad E
J Pharmacol Exp Ther; 2014 Sep; 350(3):681-90. PubMed ID: 25022512
[TBL] [Abstract][Full Text] [Related]
6. Phosphodiesterase-2 is up-regulated in human failing hearts and blunts β-adrenergic responses in cardiomyocytes.
Mehel H; Emons J; Vettel C; Wittköpper K; Seppelt D; Dewenter M; Lutz S; Sossalla S; Maier LS; Lechêne P; Leroy J; Lefebvre F; Varin A; Eschenhagen T; Nattel S; Dobrev D; Zimmermann WH; Nikolaev VO; Vandecasteele G; Fischmeister R; El-Armouche A
J Am Coll Cardiol; 2013 Oct; 62(17):1596-606. PubMed ID: 23810893
[TBL] [Abstract][Full Text] [Related]
7. Differential regulation of β2 -adrenoceptor-mediated inotropic and lusitropic response by PDE3 and PDE4 in failing and non-failing rat cardiac ventricle.
Afzal F; Aronsen JM; Moltzau LR; Sjaastad I; Levy FO; Skomedal T; Osnes JB; Qvigstad E
Br J Pharmacol; 2011 Jan; 162(1):54-71. PubMed ID: 21133887
[TBL] [Abstract][Full Text] [Related]
8. CNP regulates cardiac contractility and increases cGMP near both SERCA and TnI: difference from BNP visualized by targeted cGMP biosensors.
Manfra O; Calamera G; Froese A; Arunthavarajah D; Surdo NC; Meier S; Melleby AO; Aasrum M; Aronsen JM; Nikolaev VO; Zaccolo M; Moltzau LR; Levy FO; Andressen KW
Cardiovasc Res; 2022 May; 118(6):1506-1519. PubMed ID: 33970224
[TBL] [Abstract][Full Text] [Related]
9. 5-HT4-elicited positive inotropic response is mediated by cAMP and regulated by PDE3 in failing rat and human cardiac ventricles.
Afzal F; Andressen KW; Mørk HK; Aronsen JM; Sjaastad I; Dahl CP; Skomedal T; Levy FO; Osnes JB; Qvigstad E
Br J Pharmacol; 2008 Dec; 155(7):1005-14. PubMed ID: 18846035
[TBL] [Abstract][Full Text] [Related]
10. Altered role of C-type natriuretic peptide-activated pGC-cGMP-PDE3-cAMP signaling in hyperthyroid beating rabbit atria.
Wen JF; Quan HX; Zhou GH; Cho KW
Regul Pept; 2007 Aug; 142(3):123-30. PubMed ID: 17531330
[TBL] [Abstract][Full Text] [Related]
11. High and low gain switches for regulation of cAMP efflux concentration: distinct roles for particulate GC- and soluble GC-cGMP-PDE3 signaling in rabbit atria.
Wen JF; Cui X; Jin JY; Kim SM; Kim SZ; Kim SH; Lee HS; Cho KW
Circ Res; 2004 Apr; 94(7):936-43. PubMed ID: 14988225
[TBL] [Abstract][Full Text] [Related]
12. cGMP-PDE3-cAMP signal pathway involved in the inhibitory effect of CNP on gastric motility in rat.
Cai YL; Sun Q; Huang X; Jiang JZ; Zhang MH; Piao LH; Jin Z; Xu WX
Regul Pept; 2013 Jan; 180():43-9. PubMed ID: 23186653
[TBL] [Abstract][Full Text] [Related]
13. The natriuretic peptides BNP and CNP increase heart rate and electrical conduction by stimulating ionic currents in the sinoatrial node and atrial myocardium following activation of guanylyl cyclase-linked natriuretic peptide receptors.
Springer J; Azer J; Hua R; Robbins C; Adamczyk A; McBoyle S; Bissell MB; Rose RA
J Mol Cell Cardiol; 2012 May; 52(5):1122-34. PubMed ID: 22326431
[TBL] [Abstract][Full Text] [Related]
14. CNP-induced changes in pHi, cGMP/cAMP and mRNA expression of natriuretic peptide receptors in human trabecular meshwork cells.
Zhong L; Chu E; Chu J; Chu TC
J Ocul Pharmacol Ther; 2003 Oct; 19(5):425-36. PubMed ID: 14583135
[TBL] [Abstract][Full Text] [Related]
15. Carvedilol induces greater control of β2- than β 1-adrenoceptor-mediated inotropic and lusitropic effects by PDE3, while PDE4 has no effect in human failing myocardium.
Molenaar P; Christ T; Berk E; Engel A; Gillette KT; Galindo-Tovar A; Ravens U; Kaumann AJ
Naunyn Schmiedebergs Arch Pharmacol; 2014 Jul; 387(7):629-40. PubMed ID: 24668024
[TBL] [Abstract][Full Text] [Related]
16. Phosphodiesterases and Compartmentation of cAMP and cGMP Signaling in Regulation of Cardiac Contractility in Normal and Failing Hearts.
Calamera G; Moltzau LR; Levy FO; Andressen KW
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216259
[TBL] [Abstract][Full Text] [Related]
17. Increased effects of C-type natriuretic peptide on cardiac ventricular contractility and relaxation in guanylyl cyclase A-deficient mice.
Pierkes M; Gambaryan S; Bokník P; Lohmann SM; Schmitz W; Potthast R; Holtwick R; Kuhn M
Cardiovasc Res; 2002 Mar; 53(4):852-61. PubMed ID: 11922895
[TBL] [Abstract][Full Text] [Related]
18. SERCA2 activity is involved in the CNP-mediated functional responses in failing rat myocardium.
Moltzau LR; Aronsen JM; Meier S; Nguyen CH; Hougen K; Ørstavik Ø; Sjaastad I; Christensen G; Skomedal T; Osnes JB; Levy FO; Qvigstad E
Br J Pharmacol; 2013 Sep; 170(2):366-79. PubMed ID: 23808942
[TBL] [Abstract][Full Text] [Related]
19. PDE3, but not PDE4, reduces β₁ - and β₂-adrenoceptor-mediated inotropic and lusitropic effects in failing ventricle from metoprolol-treated patients.
Molenaar P; Christ T; Hussain RI; Engel A; Berk E; Gillette KT; Chen L; Galindo-Tovar A; Krobert KA; Ravens U; Levy FO; Kaumann AJ
Br J Pharmacol; 2013 Jun; 169(3):528-38. PubMed ID: 23489141
[TBL] [Abstract][Full Text] [Related]
20. Transgenic mice for real-time visualization of cGMP in intact adult cardiomyocytes.
Götz KR; Sprenger JU; Perera RK; Steinbrecher JH; Lehnart SE; Kuhn M; Gorelik J; Balligand JL; Nikolaev VO
Circ Res; 2014 Apr; 114(8):1235-45. PubMed ID: 24599804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
